Abstract
Objective
Lipoprotein-associated phospholipase A2 (Lp-PLA2) is among the multiple cardiovascular biomarkers that have been associated with increased cardiovascular disease. Lp-PLA2 appears, however, to be relatively unique in its high specificity for vascular inflammation as opposed to systemic inflammation, its low biologic variability, and its direct role in the causal pathway of plaque inflammation. Nevertheless, the relation between LP-PLA2 and isolated coronary artery ectasia (CAE) has not been investigated yet. The aim of our study was to assess this relation.
Methods
Twenty-five patients with isolated CAE without stenosis and 25 control subjects with angiographically normal coronary arteries were included in this study. Lp-PLA2 mass was determined in serum by a dual monoclonal antibody immuoassay.
Results
Patients with isolated CAE had significantly higher level of Lp-PLA2 compared to the control subjects with angiographically normal coronary arteries (284 ± 102 ng/ml in ectasia and 199 ± 62 ng/ml in control group, respectively, p 0.001). Also we detected a significant positive correlation between the presence of CAE and Lp-PLA2 (r = 0.452, p 0.001).
Conclusion
We have demonstrated for the first time increased Lp-PLA2 level in patients with isolated CAE, suggesting that Lp-PLA2 may be involved in the pathogenesis of CAE.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Swanton RH, Thomas ML, Coltart DJ, Jenkins BS, Web-Peplo MM, William BT (1978) Coronary artery ectasia—a variant of occlusive coronary arteriosclerosis. Br Heart J 40:393–400
Giannoglou GD, Antoniadis AP, Chatzizisis YS, Damvopoulou E, Parcharidis GE, Louridas GE (2006) Prevalence of ectasia in human coronary arteries in patients in northern Greece referred for coronary angiography. Am J Cardiol 98:314–318
Swaye PS, Fisher LD, Litwin P, Vignola PA, Judkins MP, Kemp HG et al (1983) Aneurysmal coronary artery disease. Circulation 67:134–138
Demopoulos V, Olympios C, Fakiolas C, Pissimissis EG, Economides NM, Adamopoulou E et al (1997) The natural history of aneurysmal coronary artery disease. Heart 78:136–141
Wilensky RL, Macphee CH (2009) Lipoprotein-associated phospholipase A(2) and atherosclerosis. Curr Opin Lipidol 20(5):415–420
Daniels LB, Laughlin GA, Sarno MJ, Bettencourt R, Wolfert RL, Barret-Connor E (2008) Lipoprotein-associated phospholipase A2 is an independent predictor of incident coronary heart disease in an apparently healthy older population: the Rancho Bernardo study. J Am Coll Cardiol 51(9):913–919
Wooton-Kee CR, Boyanovsky BB, Nasser MS, de williers WJ, Webb NR (2004) Group V sPLA2 hydrolysis of low-density lipoprotein results in spontaneous particle aggregation and promotes macrophage foam cell formation. Arterioscler Thromb Vasc Biol 24(4):762–767
Murakami M, Kudo I (2003) New phospholipase A2 isozymes with a potential role in atherosclerosis. Curr Opin Lipidol 14:431–436
Mallat Z, Steg PG, Benessiano J, Fox KA, Collet JP, Dabbous OH et al (2005) Circulating secretory phospholipase A activity predicts recurrent events in patient with severe acute coronary syndromes. J Am Coll Cardiol 46:1249–1257
Kolodgie FD, Burke AP, Skorija KS, Ladich E, Kutys R, Makuria AT, Virmani R (2006) Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis. Arterioscler Thromb Vasc Biol 26:2523–2529
Weintraub HS (2008) Identifying the vulnerable patient with rupture-prone plaque. Am J Cardiol 101(12A):3F–10F
Chaithiraphan S, Goldberg E, O’Reilly M (1973) Multiple aneurysms of coronary artery in sclerodermal heart disease. Angiology 24:86–93
Tang PHL, Segal AJ (1970) Polyarteritis nodosa of infancy: fatal late complications. JAMA 217:1666–1670
McKusic VA (1955) Cardiovascular aspects of Marfan’s syndrome: hereditable disorder of connective tissue. Circulation 11:321–332
Befeler B, Aranda JM, Embi A, Mullin FL, El-Sherif N, Lazzara R (1977) Coronary artery aneurysms. Study of their aetiology, clinical course and effect on left ventricular function and prognosis. Am J Med 62:597–607
Markis JE, Joffe CD, Cohn PF, Feen DJ, Herman MV, Gorlin R (1976) Clinical significance of coronary artery ectasia. Am J Cardiol 37:217–222
Ge J, Liu F, Kearney P, Gorge G, Haude M, Baumgart D, Ashry M, Erbel R (1995) Intravascular ultrasound approach to the diagnosis of coronary arteryaneurysms. Am Heart J 130:765–771
Tselepis AD, Chapman M (2002) Inflammation, bioactive lipids and atherosclerosis: potential roles of a lipoprotein-associated phospholipase A2, platelet activating factor–acetylhydrolase. Atheroscler Suppl 3:57–68
Lavi S, McConnell JP, Rihal CS, Prasad A, Mathew V, Lerman LO, Lerman A (2007) Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: association with early coronary atherosclerosis and endothelial dysfunction in humans. Circulation 115:2715–2721
Krueger D, Stierle U, Herrmann G, Simon R, Sheikhzadeh A (1999) Exercise induced myocardial ischaemia in isolated coronary artery ectasias and aneurysms (‘dilated coronaropathy’). J Am Coll Cardiol 34:1461–1470
Krüger D, ElMokhtari NE, Wieckhorst A, Simon-Herrmann G, Simon R (2010) Intravascular ultrasound study and evidence of pathological coronary flow reserve in patients with isolated coronary artery aneurysms. Clin Res Cardiol 99(3):157–164
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Korkmaz, L., Erkuş, E., Kırış, A. et al. Lipoprotein phospholipase A2 in patients with isolated coronary artery ectasia. Clin Res Cardiol 100, 511–514 (2011). https://doi.org/10.1007/s00392-010-0274-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-010-0274-z